# Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children

> **NCT02426112** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 347 (actual)

## Conditions studied

- Chronic Lung Disease
- HIV Infection

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02426112
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-09
- **Final completion:** 2019-08
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2019-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426112, "Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02426112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*